Thibault Ghesquiere
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
Journal: Journal of autoimmunity
Published: August 31, 2023
Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization.
Journal: Haematologica
Published: February 03, 2023
T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients.
Journal: European journal of internal medicine
Published: May 03, 2022
T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients.
Journal: European journal of internal medicine
Published: January 10, 2022
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD.
Journal: Frontiers in immunology
Published: December 03, 2021
Mucosal-associated invariant T cells in Giant Cell Arteritis.
Journal: Journal of autoimmunity
Published: March 18, 2021
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect.
Journal: Oncoimmunology
Published: March 04, 2021
A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects.
Journal: Clinical and experimental rheumatology
Published: February 10, 2021
Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis.
Journal: Clinical & translational immunology
Published: January 25, 2021
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia.
Journal: Journal of clinical medicine
Published: May 28, 2020
Treatment of giant cell arteritis
Journal: Presse medicale (Paris, France : 1983)
Published: March 16, 2019
Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis.
Journal: Annals of the rheumatic diseases
Published: April 10, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026